Tobias Liebregts Selected Research

Tobias Liebregts Research Topics

Disease

5	Colitis 01/2016 - 10/2002
5	Pain (Aches) 10/2013 - 02/2006
4	Inflammation (Inflammations) 01/2016 - 07/2006
3	Infections 10/2022 - 01/2019
3	Neoplasms (Cancer) 03/2022 - 01/2019
3	Respiratory Insufficiency (Respiratory Failure) 03/2022 - 01/2018
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020 - 01/2016
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2022 - 02/2019
2	COVID-19 10/2022 - 10/2020
2	Hematologic Neoplasms (Hematological Malignancy) 10/2020 - 01/2020
2	Critical Illness (Critically Ill) 03/2020 - 01/2019
2	Diarrhea 01/2016 - 03/2007
2	Dyspepsia (Indigestion) 06/2011 - 02/2006
2	Constipation 07/2010 - 03/2007
1	Dyspnea (Shortness of Breath) 10/2022
1	Hematologic Diseases (Blood Diseases) 10/2022
1	Hypercapnia 08/2021
1	Lymphopenia (Lymphocytopenia) 10/2020
1	Acute Chest Syndrome 03/2020
1	Sickle Cell Anemia (Hemoglobin S Disease) 03/2020
1	Sepsis (Septicemia) 02/2019
1	Cardio-Renal Syndrome 01/2019
1	Septic Shock (Toxic Shock Syndrome) 01/2019
1	Bronchiolitis Obliterans Syndrome 01/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2018
1	Aspergillosis 01/2018
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 05/2017
1	Colic (Abdominal Cramps) 01/2016
1	Hypersensitivity (Allergy) 10/2013
1	Vomiting 06/2011
1	Nausea 06/2011
1	Muscle Cramp (Cramp) 06/2011
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2008
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 03/2007
1	Hyperalgesia 02/2006

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 10/2013 - 07/2006
3	Ethanol (Ethyl Alcohol)IBA 10/2013 - 10/2002
3	Interleukin-2 (IL2)IBA 10/2013 - 07/2006
3	Interleukin-6 (Interleukin 6)IBA 10/2013 - 07/2006
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2022 - 01/2020
2	AcidsIBA 12/2009 - 10/2002
2	Proteins (Proteins, Gene)FDA Link 06/2008 - 02/2007
2	ImmunosorbentsIBA 02/2007 - 07/2006
2	EnzymesIBA 02/2007 - 07/2006
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 11/2022
1	Nucleic AcidsIBA 10/2022
1	Oxygen (Dioxygen)IBA 10/2022
1	Carbon DioxideIBA 08/2021
1	AntibodiesIBA 10/2020
1	fibrin fragment D (D-dimer)IBA 10/2020
1	Thomsen-Friedenreich antibodiesIBA 01/2020
1	GlobulinsIBA 01/2020
1	SteroidsIBA 10/2019
1	Hemoglobins (Hemoglobin)IBA 02/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Simendan (Levosimendan)IBA 01/2019
1	IceIBA 01/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	galactomannanIBA 01/2018
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2016
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2016
1	Trinitrobenzenesulfonic AcidIBA 10/2013
1	Transient Receptor Potential ChannelsIBA 10/2013
1	Infliximab (Remicade)FDA Link 10/2013
1	renzaprideIBA 07/2010
1	linaclotideIBA 07/2010
1	tegaserod (Zelnorm)FDA Link 07/2010
1	AnkyrinsIBA 12/2009
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2009
1	NeuropeptidesIBA 06/2008
1	LipopolysaccharidesIBA 03/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2007
1	AcetylcholinesteraseIBA 02/2006
1	itoprideIBA 02/2006
1	Dopamine D2 Receptor AntagonistsIBA 02/2006
1	peppermint oilIBA 02/2006
1	caraway oilIBA 02/2006

Therapy/Procedure

5	Hematopoietic Stem Cell Transplantation 08/2021 - 01/2016
4	Extracorporeal Membrane Oxygenation 03/2022 - 05/2017
3	Therapeutics 10/2022 - 05/2017
3	Artificial Respiration (Mechanical Ventilation) 08/2021 - 01/2019
1	Cell Transplantation 01/2020
1	Ileostomy 10/2019
1	Critical Care (Surgical Intensive Care) 01/2019
1	Stem Cell Transplantation 01/2018
1	Autologous Transplantation 01/2018
1	Drug Therapy (Chemotherapy) 01/2018